R.H. Bluestein & Co’s Equifax EFX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
– Sell
-2,565
Closed -$352K – 325
2017
Q2
$352K Hold
2,565
– – 0.02% 195
2017
Q1
$351K Hold
2,565
– – 0.02% 210
2016
Q4
$303K Sell
2,565
-1,500
-37% -$183K 0.02% 211
2016
Q3
$547K Buy
4,065
+65
+2% +$8.62K 0.04% 101
2016
Q2
$514K Hold
4,000
– – 0.04% 95
2016
Q1
$457K Sell
4,000
-1,000
-20% -$105K 0.03% 130
2015
Q4
$557K Hold
5,000
– – 0.03% 120
2015
Q3
$486K Hold
5,000
– – 0.03% 136
2015
Q2
$485K Hold
5,000
– – 0.03% 181
2015
Q1
$465K Hold
5,000
– – 0.03% 176
2014
Q4
$404K Hold
5,000
– – 0.03% 211
2014
Q3
$374K Buy
+5,000
New +$381K 0.02% 241

Other funds holding EFX

R.H. Bluestein & Co's EFX Position: Q3 2017 in Review

R.H. Bluestein & Co sold out of Equifax (EFX) in Q3 2017, closing a stake of 2,565 shares — an estimated $352K sold.

R.H. Bluestein & Co first reported a position in EFX in Q3 2014 and held it in 12 quarters. The position peaked at $557K in Q4 2015. 520 funds tracked by Wall St. Rank hold EFX as of Q3 2017.

  • R.H. Bluestein & Co reported no remaining Equifax position as of Q3 2017 after selling out during the quarter.
  • R.H. Bluestein & Co sold 2,565 Equifax shares in Q3 2017, an estimated $352K.
  • R.H. Bluestein & Co first reported a position in Equifax in Q3 2014 and held it in 12 quarters.
  • R.H. Bluestein & Co's Equifax position peaked at $557K in Q4 2015.
  • 520 funds tracked by Wall St. Rank held Equifax as of Q3 2017.

Based on R.H. Bluestein & Co's 13F filing for Q3 2017, filed 13 Nov 2017.